sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Apr-2014 12:37
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 201-225 out of 894.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>

Public Release: 22-Oct-2013
McGill/MUHC research team wins global innovation award for HIVSmart self-screening strategy and app
The Research Institute of the McGill University Health Centre and McGill University congratulate the team led by Dr. Nitika Pant Pai for receiving the international 2013 Accelerating Science Award Program. The team won global recognition for developing an innovative self-test screening strategy for the HIV. The award, funded by Public Library of Science, Google and Wellcome Trust, recognizes scientific innovations borne out of Open Access research that address real world challenges.
Public Library of Science, Google, Wellcome Trust

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-934-1934 x71381
McGill University Health Centre

Public Release: 22-Oct-2013
Proceedings of the National Academy of Sciences
New artificial protein mimics a part of the HIV outer coat
A team of scientists at Duke Medicine and Memorial Sloan-Kettering Cancer Center has created an artificial protein coupled with a sugar molecule that mimics a key site on the outer coat of HIV where antibodies can bind to neutralize a wide variety of HIV strains.
NIH/National Institute of Allergy and Infectious Diseases, Bill and Melinda Gates Foundation

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 22-Oct-2013
Biochemistry
BUSM researchers make a case for free fatty acids
In a recent study in the journal Biochemistry, a research group led by James A. Hamilton, PhD, professor of physiology, biophysics and radiology at Boston University School of Medicine, applied novel fluorescent methods to measure the rate by which fatty acids bind to and move across the fatty acid membrane to become metabolized.

Contact: Gina Orlando
gina.orlando@bmc.org
617-638-8490
Boston University Medical Center

Public Release: 22-Oct-2013
Lauren Sciences LLC research team at Ben-Gurion University successfully completes Campbell Foundation 1-year grant to develop V-SmartTM therapeutic for neuro-HIV
Lauren Sciences, a privately-held biotechnology company furthering development of V-Smart™ therapeutics based upon its novel nanovesicle platform technology, announced today successful completion by its research team at Ben-Gurion University of the first stage of developing a V-Smart™ therapeutic for the treatment of neuro-HIV. The development of this V-Smart™ therapeutic, that systemically delivers tenofovir across the blood brain barrier into the brain for treatment of neuro-HIV, was supported by a grant from The Campbell Foundation.
Campbell Foundation

Contact: Susan Rosenbaum
info@laurensciences.com
917-397-2826
Lauren Sciences LLC

Public Release: 21-Oct-2013
American Journal of Public Health
Study of decline of malaria in the US could affect approach to malaria epidemic abroad, UT Arlington researcher says
A study of the eradication of the mosquito-borne disease in the US has implications for the approach to malaria abroad, says Daniel Sledge, assistant professor of political science.

Contact: Bridget Lewis
blewis@uta.edu
817-272-3317
University of Texas at Arlington

Public Release: 21-Oct-2013
IPM receives 2 awards from USAID through PEPFAR to advance HIV prevention technologies for women
The International Partnership for Microbicides announced today that it has received two competitive five-year awards with a combined US$40 million ceiling from the US Agency for International Development provided through the US President's Emergency Plan for AIDS Relief (PEPFAR). Both awards aim to advance new HIV prevention tools for women and to help ensure their availability in developing countries where the epidemic has hit hardest.

Contact: Holly Seltzer
hseltzer@IPMglobal.org
301-608-4277
International Partnership for Microbicides (IPM)

Public Release: 21-Oct-2013
URC leads new USAID project to improve Haiti's health care system
University Research Co., LLC is leading a new project in Haiti, a country with complex public health issues, to improve the population's health status. The project, called Quality Health Services for Haiti (Services de Santé de Qualité pour Haïti – SSQH) North, is funded by the US Agency for International Development. URC and its partners will support the Haitian Ministry of Public Health and Population to increase the use and quality of its primary care and community services.
US Agency for International Development

Contact: Elizabeth Ransom
eransom@urc-chs.com
301-941-8442
University Research Co., LLC

Public Release: 21-Oct-2013
Proceedings of the National Academy of Sciences
Breast milk protein may be key to protecting babies from HIV infection
A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine.
Doris Duke Charitable Foundation, Duke University School of Medicine, Center for HIV/AIDS Vaccine Immunology, NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 18-Oct-2013
Journal of Applied Physics
Salmonella sensing system
Foodborne illnesses spread easily and, as such, are a difficult-to-control problem -- even more so in developing nations. Quick detection can play a critical role in halting the spread of contamination. Traditional detection methods, however, tend to be haltingly slow. Recognizing the need for a real-time biosensing system to detect pathogenic bacteria, a team at Auburn University came up with a novel design, which they describe in the AIP's Journal of Applied Physics.

Contact: Jason Socrates Bardi
jbardi@aip.org
240-535-4954
American Institute of Physics

Public Release: 17-Oct-2013
PLOS Neglected Tropical Diseases
5-year-old children are as likely to suffer from bilharzia as their mothers
Children of women harboring the bilharzia (schistosomiasis) worm during pregnancy are more likely to suffer the infection by the age of five years, a new study publishing Oct. 17, 2013, in the journal PLOS Neglected Tropical Diseases has found.

Contact: Dr. Robert Tweyongyere
tmrobert966@gmail.com
PLOS

Public Release: 17-Oct-2013
PLOS Neglected Tropical Diseases
Pioneering use of oral cholera vaccine during outbreak
A Medecins Sans Frontieres vaccination campaign of more than 300,000 people in Guinea shows feasibility of oral cholera vaccine for control of future epidemics.
Médecins Sans Frontières

Contact: Sandra Murillo
Sandra.Murillo@newyork.msf.org
212-763-5765
PLOS

Public Release: 17-Oct-2013
PLOS Neglected Tropical Diseases
Human neutrophil peptide-1: A new anti-leishmanial drug candidate
As drug-resistant strains of Leishmaniasis spread, new non-toxic therapy could open a new front in the battle against this deadly parasite.
Pasteur Institute of Iran

Contact: Sima Rafati
sima-rafatisy@pasteur.ac.ir
98-216-695-3311 x21
PLOS

Public Release: 16-Oct-2013
PLOS ONE
Rapid blood test to diagnose sepsis at the bedside could save thousands of lives, study suggests
Researchers at King's College London have identified a biomarker -- a biological 'fingerprint' -- for sepsis in the blood, and showed it could be possible to diagnose the condition within two hours by screening for this biomarker at a patient's bedside.
Guy's and St Thomas' Charity, UK National Institute for Health Research

Contact: Katherine Barnes
katherine.barnes@kcl.ac.uk
44-207-848-3076
King's College London

Public Release: 15-Oct-2013
Canadian Medical Association Journal
Iron supplementation can provide cognitive and physical benefits to anemic children
Giving daily iron supplements to anemic primary-school-aged children can have cognitive and physical benefits, according to a study published in CMAJ.

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal

Public Release: 10-Oct-2013
A*STAR and NUS launch joint center to advance research on nutrition
The National University of Singapore (NUS) and A*STAR will be jointly establishing the S$148 million Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Development. This collaboration between the NUS's Yong Loo Lin School of Medicine and A*STAR's Singapore Institute for Clinical Sciences is set to become the leading center in Asia for research in the nexus between nutritional sciences, metabolic diseases and human development.
A*STAR, NUS

Contact: Vithya Selvam
vithya_selvam@a-star.edu.sg
656-826-6291
Agency for Science, Technology and Research (A*STAR), Singapore

Public Release: 10-Oct-2013
Mayo Clinic Proceedings
Study finds high-risk travelers account for nearly 1 in 5 persons seeking pre-travel advice
Researchers from Boston University Schools of Medicine and Public Health and Boston Medical Center have found that high-risk travelers account for nearly 20 percent of patients using the five clinics of the Boston Area Travel Medicine Network. The study, which appears online in Mayo Clinic Proceedings, also found that these travelers often visited destinations with malaria and typhoid risk.
Centers for Disease Control and Prevention, Boston Medical

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center

Public Release: 9-Oct-2013
New initiative supports research to strengthen health systems in low- and middle-income countries
The Wellcome Trust, the Department for International Development, the Medical Research Council and the Economic and Social Research Council today announced a £15 million collaboration to support research that will generate practical measures to improve health systems in low- and middle-income countries.
Wellcome Trust

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust

Public Release: 9-Oct-2013
American Journal of Tropical Medicine and Hygiene
New studies show cholera emerging as a driver of progress in public health in Haiti
The deadly cholera epidemic that rocked earthquake-shattered Haiti in 2010, claiming 8,000 lives and counting, has rallied the public health community to seek water and sewer improvements that, combined with vaccination, could prevent some 89,000 future cholera infections. These findings are among the many insights published this month in a special section of the American Journal of Tropical Medicine and Hygiene documenting the public health response to the largest national cholera outbreak in modern history.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 8-Oct-2013
AIDS Vaccine 2013
HIV vaccines elicit immune response in infants
A new analysis of two HIV vaccine trials that involved pediatric patients shows that the investigational vaccines stimulated a critical immune response in infants born to HIV-infected mothers, researchers at Duke Medicine report.

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 8-Oct-2013
Pediatrics
Combination of anemia and high altitude increases poor outcomes in children with pneumonia
Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes -- including persistent pneumonia, secondary infections, organ failure or death -- in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes.
World Health Organization, National Institutes of Health

Contact: Kory Dodd Zhao
kzhao2@partners.org
617-726-0274
Massachusetts General Hospital

Public Release: 8-Oct-2013
Innovation Days 2013
LSTM Professor Richard Pleass wins Prix de l'Innovation 2013
Professor Richard Pleass has won the Prix de l'Innovation 2013, also known as the Universal Biotech Innovation Prize 2013.

Contact: Clare Bebb
c.bebb@liv.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine

Public Release: 8-Oct-2013
2013 Victoria Prize rewards quest to eradicate malaria
Malaria researcher professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria.
Victorian Government

Contact: Alan Gill
gill.a@wehi.edu.au
61-419-591-102
Walter and Eliza Hall Institute

Public Release: 7-Oct-2013
AIDS
South Africa reverses mortality trend in children under 5
Over the past decade, South Africa has made a dramatic reversal in child survival -- mainly because of improvements in HIV/AIDS care, reports a study in AIDS, official journal of the International AIDS Society. AIDS is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 7-Oct-2013
6th Multilateral Initiative on Malaria Pan-African Conference
Malaria vaccine candidate reduces disease over 18 months of follow-up in phase 3 children's study
Results from a large-scale Phase 3 trial, presented today in Durban, show that the most clinically advanced malaria vaccine candidate, RTS,S, continued to protect young children and infants from clinical malaria up to 18 months after vaccination. Based on these data, GSK now intends to submit, in 2014, a regulatory application to the European Medicines Agency.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 7-Oct-2013
Proceedings of the National Academy of Sciences
Scientists find soaring variety of malaria parasites in bats
Researchers have discovered a surprising diversity of malaria parasites in West African bats as well as new evidence of evolutionary jumps to rodent hosts. Led by scientists at the American Museum of Natural History, the Max Planck Institute for Infection Biology, and the Museum für Naturkunde, Berlin, the new study reveals that two bat-infecting parasites are closely related to parasites in rodents that are commonly used to model human malaria in laboratory studies.
National Science Foundation, American Museum of Natural History, The Max Planck Society

Contact: Kendra Snyder
ksnyder@amnh.org
212-496-3419
American Museum of Natural History

Showing releases 201-225 out of 894.

<< < 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 > >>